SARS/SARS-CoV-2 Nucleocapsid Polyclonal Antibody | Invitrogen PA5-81794 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

SARS/SARS-CoV-2 Nucleocapsid Polyclonal Antibody

catalog :

PA5-81794

quantity :

100 uL

price :

US 474.00

clonality :

polyclonal

host :

domestic rabbit

conjugate :

nonconjugated

reactivity :

SARS-CoV-2

application :

western blot, ELISA

citations: 6

Reference
Amanat F, Strohmeier S, Meade P, Dambrauskas N, Muhlemann B, Smith D, et al. Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus. PLoS Biol. 2021;19:e3001384 pubmed publisher
Bagasra O, Pandey P, Sanamandra J, Houston J, McLean E, Albrecht H. Infectivity of Human Olfactory Neurons to SARS-CoV-2: A Link to Anosmia. Oman Med J. 2021;36:e307 pubmed publisher
Esmail S, Knauer M, Abdoh H, Voss C, Chin Yee B, Stogios P, et al. Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies. Cell Rep Methods. 2021;1:100011 pubmed publisher
Voss C, Esmail S, Liu X, Knauer M, Ackloo S, Kaneko T, et al. Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern. JCI Insight. 2021;6: pubmed publisher
Amanat F, Strohmeier S, Rathnasinghe R, Schotsaert M, Coughlan L, Garcia Sastre A, et al. Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. MBio. 2021;12: pubmed publisher
Amanat F, Strohmeier S, Rathnasinghe R, Schotsaert M, Coughlan L, Garcia Sastre A, et al. Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model. bioRxiv. 2020;: pubmed publisher

product information

Product Type :

Antibody

Product Name :

SARS/SARS-CoV-2 Nucleocapsid Polyclonal Antibody

Catalog # :

PA5-81794

Quantity :

100 uL

Price :

US 474.00

Clonality :

Polyclonal

Purity :

Antigen affinity chromatography, Protein A

Host :

Rabbit

Reactivity :

Virus

Applications :

ELISA: 1:5,000-1:10,000, Western Blot: 1:1,000-1:5,000

Species :

Virus

Isotype :

IgG

Storage :

Store at 4 C short term. For long term storage, store at -20 C, avoiding freeze/thaw cycles.

Description :

SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. The SARS-CoV-2 N protein is an abundant RNA-binding protein critical for viral genome packaging, yet the molecular details that involve this process are poorly understood. N protein contains three dynamic disordered regions that house putative transiently-helical binding motifs. The two folded domains interact minimally such that full-length N protein is a flexible and multivalent RNA-binding protein. SARS-CoV-2 causes illnesses ranging from the common cold to severe diseases.

Immunogen :

Recombinant Human SARS Coronavirus Nucleoprotein/NP Protein

Format :

Liquid

Applications w/Dilutions :

ELISA: 1:5,000-1:10,000, Western Blot: 1:1,000-1:5,000

Aliases :

COVID19 Nucleocapsid; COVID-19 nucleocapsid; COVID19 Spike nucleocapsid; SARS-CoV-2 N